Detection of disseminated tumor cells in patients with gynecological cancers

Gynecologic Oncology

Volumn 103, Issue 3, 2006, Pages 942-947

  Fehm, T ^a   Becker, S ^a   Bachmann, C ^a   Beck, V ^a   Gebauer, G ^b   Banys, M ^a   Wallwiener, D ^a   Solomayer, E F ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Bone marrow; Cervical cancer; Endometrial cancer; Ovarian cancer; Tumor cell dissemination

Indexed keywords

CYTOKERATIN; CYTOKERATIN ANTIBODY;

ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FEMALE; GERMANY; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL; UTERINE CERVIX CANCER;

BONE MARROW; ENDOMETRIAL NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NEOPLASM CIRCULATING CELLS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; UTERINE CERVICAL NEOPLASMS;

EID: 33750211968     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.05.049     Document Type: Article

References (37)

1. Braun S., Pantel K., Muller P., Janni W., Hepp F., Kentenich C.R., et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N. Engl. J. Med. 342 (2000) 525-533
2. Mansi J.L., Gogas H., Bliss J.M., Gazet J.C., Berger U., and Coombes R.C. Outcome of primary breast cancer patients with micrometastases: a long-term follow-up study. Lancet 354 (1999) 197-202
3. Wiedswang G., Borgen E., Karesen R., Kvalheim G., Nesland J.M., Qvist H., et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J. Clin. Oncol. 21 18 (2003) 3469-3478
4. Gebauer G., Fehm T., Merkle E., Beck E.P., Lang N., and Jager W. Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up. J. Clin. Oncol. 19 16 (2001) 3669-3674
5. Braun S., Vogl F.D., Naume B., Janni W., Osborne M.P., Coombes R.C., et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N. Engl. J. Med. 353 8 (2005) 793-802
6. Solomayer E.F., Diel I.J., Salanti G., Hahn M., Gollan C., Schutz F., et al. Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients. Clin. Cancer Res. 7 12 (2001) 4102-4108
7. Pantel K., and Brakenhoff R.H. Dissecting the metastatic cascade. Nat. Rev., Cancer 4 (2004) 448-456
8. Fidler I.J. Metastasis: quantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2′-deoxyuridine. N. Engl. J. Med. 353 8 (2005) 793-802
9. Liotta L.A., Kleinerman J., and Saidel G.M. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res. 34 5 (1974) 997-1004
10. Butler T.P., and Gullino P.M. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res. 35 3 (1975) 512-516
11. Chausovsky G., Luchansky M., Figer A., Shapira J., Gottfried M., Novis B., et al. Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas, colon, stomach, and lung. Cancer 86 11 (1999) 2398-2405
12. Lukyanchuk V.V., Friess H., Kleeff J., Osinsky S.P., Ayuni E., Candinas D., et al. Detection of circulating tumor cells by cytokeratin 20 and prostate stem cell antigen RT-PCR in blood of patients with gastrointestinal cancers. Anticancer Res. 23 3B (2003) 2711-2716
13. Sehouli J., Konsgen D., Nimpsch R., Stengel D., Oskay G., Mustea A., et al. Prognostic significance of epithelial cells in the blood of patients with gynaecological malignancies. Anticancer Res. 3 5b (2003) 4133-4140
14. Bauer K.D., de la Torre-Bueno J., Diel I.J., Hawes D., Decker W.J., Priddy C., et al. Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging. Clin. Cancer Res. 6 9 (2000) 3552-3559
15. Fehm T, Braun S, Müller V, Janni W, Gebauer G, Marth C. et al. A concept for the standardized detection of disseminated tumor cells (DTC) in bone marrow of patients with primary breast cancer and its clinical implementation. Cancer (in press).
16. Borgen E., Naume B., Nesland J.M., Kvalheim G., Beiske K., Fodstad O., et al. Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. Establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy 5 (1999) 377-388
17. Scheungraber C., Muller B., Kohler C., Possover M., Leistritz S., Schneider A., et al. Detection of disseminated tumor cells in patients with cervical cancer. J. Cancer Res. Clin. Oncol. 128 6 (2002) 323-329
18. Janni W., Hepp F., Strobl B., Rack B., Rjosk D., Kentenich C., et al. Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus. Cancer 97 2 (2003) 405-411
19. Dong S.M., Pai S.I., Rha S.H., Hildesheim A., Kurman R.J., Schwartz P.E., et al. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol. Biomarkers Prev. 11 1 (2002) 3-6
20. Yuan C.C., Wang P.H., Ng H.T., Li Y.F., Huang T.S., Chen C.Y., et al. Detecting cytokeratin 19 mRNA in the peripheral blood cells of cervical cancer patients and its clinical-pathological correlation. Gynecol. Oncol. 85 1 (2002) 148-153
21. Tseng C.J., Pao C.C., Lin J.D., Soong Y.K., Hong J.H., and Hsueh S. Detection of human papillomavirus types 16 and 18 mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis. J. Clin. Oncol. 17 5 (1999) 1391-1396
22. Stenman J., Lintula S., Hotakainen K., Vartiainen J., Lehvaslaiho H., and Stenman U.H. Detection of squamous-cell carcinoma antigen-expressing tumour cells in blood by reverse transcriptase-polymerase chain reaction in cancer of the uterine cervix. Int. J. Cancer 74 1 (1997) 75-80
23. Pao C.C., Hor J.J., Yang F.P., Lin C.Y., and Tseng C.J. Detection of human papillomavirus mRNA and cervical cancer cells in peripheral blood of cervical cancer patients with metastasis. J. Clin. Oncol. 15 3 (1997) 1008-1012
24. Braun S., Schindlbeck C., Hepp F., Janni W., Kentenich C., Riethmuller G., et al. Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse. J. Clin. Oncol. 19 2 (2001) 368-375
25. Roggel F., Hocke S., Lindemann K., Sinz S., Welk A., Bosl M., et al. Minimal residual disease in breast cancer and gynecological malignancies: phenotype and clinical relevance. Recent Results Cancer Res. 162 (2003) 89-100
26. Marth C., Kisic J., Kaern J., Trope C., and Fodstad O. Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis. Cancer 94 3 (2002) 707-712
27. Ji X.Q., Sato H., Tanaka H., Konishi Y., Fujimoto T., Takahashi O., et al. Real-time quantitative RT-PCR detection of disseminated endometrial tumor cells in peripheral blood and lymph nodes using the LightCycler System. Gynecol. Oncol. 100 2 (2006) 355-360
28. Klein A., Fishman A., Zemer R., Zimlichman S., and Altaras M.M. Detection of tumor circulating cells by cytokeratin 20 in the blood of patients with endometrial carcinoma. Gynecol. Oncol. 78 (2000) 352-355
29. Cormio G., Rossi C., Cazzolla A., Resta L., Loverro G., Greco P., et al. Distant metastases in ovarian carcinoma. Int. J. Gynecol. Cancer 13 2 (2003) 125-129
30. Fagundes H., Perez C.A., Grigsby P.W., and Lockett M.A. Distant metastases after irradiation alone in carcinoma of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 24 2 (1992) 377-380
31. Ratanatharathorn V., Powers W.E., Steverson N., Han I., Ahmad K., and Grimm J. Bone metastasis from cervical cancer. Cancer 73 9 (1994) 2372-2379
32. Mariani A., Webb M.J., Keeney G.L., Calori G., and Podratz K.C. Hematogenous dissemination in corpus cancer. Gynecol. Oncol. 80 2 (2001) 233-238
33. Puricelli L., Gomez D.E., Vidal M.C., Eijan A.M., Spinelli O., Alonso D.F., de Lustig E.S., et al. Effect of host-organ environment on the in vivo and in vitro behaviour of a murine mammary adenocarcinoma. Tumour Biol. 15 5 (1994) 284-293
34. Sipkins D.A., Wei X., Wu J.W., Runnels J.M., Cote D., Means T.K., et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 435 7044 (2005) 969-973
35. Janni W., Rack B., Schindlbeck C., Strobl B., Rjosk D., Braun S., et al. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence. Cancer 103 (2005) 884-891
36. Wiedswang G., Borgen E., Karesen R., Qvist H., Janbu J., Kvalheim G., Nesland J.M., et al. Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome. Clin. Cancer Res. 10 (2004) 5342-5348
37. Ji X.Q., Sato H., Tanaka H., Konishi Y., Fujimoto T., Takahashi O., et al. Real-time quantitative RT-PCR detection of disseminated endometrial tumor cells in peripheral blood and lymph nodes using the LightCycler System. Gynecol. Oncol. 100 2 (2006) 355-360